Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01968356 · ClinicalTrials.gov registry record · Phase 3

In-vivo Efficacy Study of Patient Preoperative Preps

A Phase 3 study, sponsored by Solventum US.

Terminated
Registry status
Phase 3
Development phase
171
Enrollment target

NCT01968356: Clinical Trial Phase 3 study, sponsored by Solventum US.

NCT01968356 is a Phase 3 study that was terminated before completion, run by Solventum US. The registered enrollment target is 171 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01968356, a Phase 3 study, was terminated before completion, sponsored by Solventum US.

TERMINATED
Registry status
Phase 3
Development phase
171 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the antimicrobial efficacy of the 3M CHG/IPA Prep on skin flora of the abdominal and inguinal regions of human subjects.

Primary Outcome

On the abdominal region a responder was a subject with a 2-log10/cm2 bacterial reduction at 10 minutes and for whom the skin flora did not return to baseline at 6 hours. On the inguinal region a responder was a subject with a 3-log10/cm2 bacterial reduction at 10 minutes and for whom the skin flora did not return to baseline at 6 hours.

Interventions

  • DRUG Saline
  • DRUG ChloraPrep
  • DRUG 3M CHG/IPA Prep Colorless
  • DRUG 3M CHG/IPA Prep Tint

Trial Details

FieldValue
Enrollment Target 171 participants
Start Date 2013-10
Est. Completion 2014-01
Phase Phase 3
Solventum US

41 total trials

Why NCT01968356 stopped before completion

NCT01968356 is an interventional study that assigns participants to a tested intervention. The registered 171 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (78% lower).

The record links to 0 conditions, and to 4 interventions - of which Saline is the first listed.

NCT01968356 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01968356 about?

NCT01968356 is a clinical study titled "In-vivo Efficacy Study of Patient Preoperative Preps". The purpose of this study is to evaluate the antimicrobial efficacy of the 3M CHG/IPA Prep on skin flora of the abdominal and inguinal regions of human subjects.

What is the current status of trial NCT01968356?

This trial is currently terminated. It is a Phase 3 study. The enrollment target is 171 participants. The study started on 2013-10. Estimated completion is 2014-01.

What interventions are being tested in trial NCT01968356?

The interventions under investigation include: Saline (DRUG), ChloraPrep (DRUG), 3M CHG/IPA Prep Colorless (DRUG), 3M CHG/IPA Prep Tint (DRUG).

Who is sponsoring clinical trial NCT01968356?

This trial is sponsored by Solventum US, which has 41 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01968356's enrollment target sits among peer trials

171 1451st of 2000 higher than 548 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02641145 · 171 participants · NA

    Molecular Imaging of Primary Amyloid Cardiomyopathy

  • NCT05541029 · 171 participants · NA

    Music Listening: A Mechanistic Trial

  • NCT05561127 · 171 participants · Phase 3

    Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel

  • NCT05592938 · 171 participants · NA

    Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01968356, the US trial registry maintained by the National Library of Medicine. NCT01968356 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.